Prognostic role of mesangial IgM deposition in IgA nephropathy: a long-term cohort study

References

• McGrogan A, Franssen CF, de Vries CS. The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. Nephrol Dial Transplant. 2011;26(2):1–7. doi:10.1093/ndt/gfq665.
   PubMed Web of Science ®Google Scholar
• O'Shaughnessy MM, Hogan SL, Thompson BD, et al. Glomerular disease frequencies by race, sex and region: results from the international kidney biopsy survey. Nephrol Dial Transplant. 2018;33(4):661–669. doi:10.1093/ndt/gfx189.
   PubMed Web of Science ®Google Scholar
• Maillard N, Mariat C. The oxford classification for immunoglobulin a nephropathy: a common language blurred by dissonant voices. Nephrol Dial Transplant. 2019;34(10):1617–1618. doi:10.1093/ndt/gfz009.
   PubMed Web of Science ®Google Scholar
• Ștefan G, Stancu S, Zugravu A, et al. Immunosuppressive therapy versus supportive care in IgA nephropathy patients with stage 3 and 4 chronic kidney disease. Medicine (Baltimore). 2022;101(36):e30422. doi:10.1097/MD.0000000000030422.
   PubMed Web of Science ®Google Scholar
• Trimarchi H, Barratt J, Cattran DC, et al. Oxford classification of IgA nephropathy 2016: an update from the IgA nephropathy classification working group. Kidney Int. 2017;91(5):1014–1021. doi:10.1016/j.kint.2017.02.003.
   PubMed Web of Science ®Google Scholar
• Ştefan G, Ismail G, Stancu S, et al. Validation study of oxford classification of IgA nephropathy: the significance of extracapillary hypercellularity and mesangial IgG immunostaining. Pathol Int. 2016;66(8):453–459. doi:10.1111/pin.12442.
   PubMed Web of Science ®Google Scholar
• Shin DH, Lim BJ, Han IM, et al. Glomerular IgG deposition predicts renal outcome in patients with IgA nephropathy. Mod Pathol. 2016;29(7):743–752. doi:10.1038/modpathol.2016.77.
   PubMed Web of Science ®Google Scholar
• Liu Z, Li L. [Significance of IgM deposition in IgA nephropathy: an appraisal based on renal re-biopsy]. Zhonghua Yi Xue Za Zhi. 1990;70(6):324–326, 24.
   PubMedGoogle Scholar
• Welch TR, McAdams J. Immunoglobulin M and C1q mesangial labeling in IgA nephropathy. Am J Kidney Dis. 1998;32(4):589–592. doi:10.1016/s0272-6386(98)70021-6.
   PubMed Web of Science ®Google Scholar
• Heybeli C, Oktan MA, Yıldız S, et al. Clinical significance of mesangial IgM deposition in patients with IgA nephropathy. Clin Exp Nephrol. 2019;23(3):371–379. doi:10.1007/s10157-018-1651-6.
   PubMed Web of Science ®Google Scholar
• Heybeli C, Unlu M, Yildiz S, et al. IgA nephropathy: association of C4d with clinical and histopathological findings and possible role of IgM. Ren Fail. 2015;37(9):1464–1469. doi:10.3109/0886022X.2015.1077319.
   PubMed Web of Science ®Google Scholar
• Moriyama T, Shimizu A, Takei T, et al. Characteristics of immunoglobulin a nephropathy with mesangial immunoglobulin G and immunoglobulin M deposition. Nephrology (Carlton). 2010;15(8):747–754. doi:10.1111/j.1440-1797.2010.01296.x.
   PubMed Web of Science ®Google Scholar
• Obrișcă B, Ștefan G, Gherghiceanu M, et al. “Associated” or “secondary” IgA nephropathy? An outcome analysis. PLoS One. 2019;14(8):e0221014. doi:10.1371/journal.pone.0221014.
   PubMed Web of Science ®Google Scholar
• Ștefan G, Terinte-Balcan G, Stancu S, et al. IgA nephropathy with serum ANCA positivity: case series and literature review. Rheumatol Int. 2021;41(7):1347–1355. doi:10.1007/s00296-021-04888-2.
   PubMed Web of Science ®Google Scholar
• Sethi S, Haas M, Markowitz GS, et al. Mayo clinic/renal pathology society consensus report on pathologic classification, diagnosis, and reporting of GN. J Am Soc Nephrol. 2016;27(5):1278–1287. May doi:10.1681/ASN.2015060612.
   PubMed Web of Science ®Google Scholar
• Terinte-Balcan G, Stancu S, Zugravu A, et al. Prognostic role of glomerular electron microscopy lesions in IgA nephropathy: “the devil is in the details”. J Nephrol. 2023;36(8):2233–2243. doi:10.1007/s40620-023-01744-3.
   PubMed Web of Science ®Google Scholar
• Terinte-Balcan G, Stefan G. A closer look: ultrastructural evaluation of high-risk progression IgA nephropathy. Ultrastruct Pathol. 2023;47(6):461–469.
   PubMed Web of Science ®Google Scholar
• Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol. 2007;165(6):710–718. doi:10.1093/aje/kwk052.
   PubMed Web of Science ®Google Scholar
• Xiong L, Liu L, Tao Y, et al. Clinical significance of IgM and C3 deposition in children with primary immunoglobulin a nephropathy. J Nephrol. 2023;36(8):2213–2222. doi:10.1007/s40620-023-01724-7.
   PubMed Web of Science ®Google Scholar
• Barratt J, Lafayette RA, Zhang H, et al. IgA nephropathy: the lectin pathway and implications for targeted therapy. Kidney Int. 2023;104(2):254–264. doi:10.1016/j.kint.2023.04.029.
   PubMed Web of Science ®Google Scholar
• Zhang M, Takahashi K, Alicot EM, et al. Activation of the lectin pathway by natural IgM in a model of ischemia/reperfusion injury. J Immunol. 2006;177(7):4727–4734. doi:10.4049/jimmunol.177.7.4727.
   PubMed Web of Science ®Google Scholar
• Auriti C, Prencipe G, Moriondo M, et al. Mannose-binding lectin: biologic characteristics and role in the susceptibility to infections and ischemia-reperfusion related injury in critically ill neonates. J Immunol Res. 2017;2017:7045630–7045611. doi:10.1155/2017/7045630.
   PubMed Web of Science ®Google Scholar
• Strassheim D, Renner B, Panzer S, et al. IgM contributes to glomerular injury in FSGS. J Am Soc Nephrol. 2013;24(3):393–406. doi:10.1681/ASN.2012020187.
   PubMed Web of Science ®Google Scholar
• Zhang YM, Gu QH, Huang J, et al. Clinical significance of IgM and C3 glomerular deposition in primary focal segmental glomerulosclerosis. Clin J Am Soc Nephrol. 2016;11(9):1582–1589. doi:10.2215/CJN.01190216.
   PubMed Web of Science ®Google Scholar